jehan

When FDA met Q-PORTFOLIO: why the rave reviews are relevant to Modus Outcomes

Last week, Modus Outcomes’ own Stefan Cano (https://modusoutcomes.com/stefan-cano/), together with Professors Anne Klassen (McMaster University; https://fhs.mcmaster.ca/ceb/faculty_member_klassen.htm) and Andrea Pusic (Memorial Sloan Kettering Cancer Center; https://www.mskcc.org/cancer-care/doctors/andrea-pusic), visited the Center for Devices and Radiological Health (CDRH) at the US Food and Drug Administration. This is the third time the trio has been invited by FDA to present […]

Stefan Cano invited by FDA

On September 13th, together with Professor Anne Klassen (McMaster University) and Dr Andrea Pusic (Memorial Sloan Kettering Cancer Center), Stefan will be visiting the Center for Devices and Radiological Health (CDRH) at the US Food and Drug Administration. This will be the third time Stefan, Anne and Andrea have been invited by FDA to present […]

SPIRIT-PRO Consensus meeting Birmingham, UK, 11-12 May 2017

Antoine Regnault, Modus Outcomes’ Global Lead – Statistics, was a panel member of the SPIRIT-PRO consensus meeting that was held in Birmingham, UK on May 11-12, 2017. SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) is an international initiative that aims to improve the quality of clinical trial protocols by defining an evidence-based set of […]